Evaluating and improving orphan drug regulations in Europe: A Delphi policy study
-
Amarantus Bioscience Receives Notice Of Allowance For U.S. Patent Application Covering Proprietary Compositions Of Matter And Methods Of Use for manufacture -Courtesy (Biospace)
Pharma Live, , Intellectual Property Rights, 0
SAN FRANCISCO and GENEVA, May 5, 2015 (GLOBE NEWSWIRE) — Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on...
-
Patent Safe Harbor Applies To Supplemental New Drug Applications
Pharma Live, , Intellectual Property Rights, 0
POSTED BY JACOB D. MOORE AND COURTENAY C. BRINCKERHOFF ON 21 MAY 2015POSTED IN FEDERAL CIRCUIT DECISIONS;INFRINGEMENTOn May 13, 2015, the Federal Circuit confirmed...
-
The face of the patent is not the ‘‘Whole Story’’: determining effective life of a pharmaceutical patent in the United States
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0172219004000675-mainDownload
-
Louisiana Challenge’s AstraZeneca on Antitrust Claims for Asserting Invalid Drug Patents – Courtesy(PATENTLYO)
Pharma Live, , Intellectual Property Rights, 0
In March 2015, the state of Louisiana filed suit against AstraZeneca alleging antitrust violations based upon the company’s actions of...
-
To Study The Scope & Importance Of Amended Patent Act On Indian Pharmaceutical Company With Respect To Innovation
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s2212567114002469-mainDownload
-
Frequently Asked Questions on Patents and Exclusivity
Pharma Live, , Intellectual Property Rights, 0
What is the difference between patents and exclusivity? Patents and exclusivity work in a similar fashion but are distinctly...
-
FDA Releases Draft Guidance on Biosimilars
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 9 FEBRUARY 2012POSTED IN BIOSIMILARSOn February 9, 2012, the FDA issued long-awaited (draft) guidance documents on...
-
Review on Development of Orphan Drug for Rare disease
Pharma Live, , Intellectual Property Rights, 0
ABOUT AUTHORS:Kamshette Sharada*, Poul Bhagwat, Ghodke AmolDepartment of Quality Assurance,Maharashtra College of Pharmacy,Nilanga, Maharashtra, India.*[email protected] ABSTRACTSimply receiving a diagnosis...
![](https://ml7mn4k5dnn0.i.optimole.com/w:289/h:289/q:eco/f:best/https://interactivepharm.com/wp-content/uploads/2022/08/Show-your.jpg)